Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of NGEN will decline by -6.56% over the next 2 Weeks and hit $3.42 by Monday, May 18, 2026. In that time frame, NGEN's share price is expected to range between $3.24 and $3.60.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 18, 2026 | 3.24 | 3.42 | 3.60 |
| May 15, 2026 | 3.17 | 3.34 | 3.52 |
| May 14, 2026 | 3.36 | 3.54 | 3.69 |
| May 13, 2026 | 3.39 | 3.58 | 3.75 |
| May 12, 2026 | 3.34 | 3.52 | 3.70 |
| May 11, 2026 | 3.36 | 3.54 | 3.73 |
| May 8, 2026 | 3.28 | 3.46 | 3.64 |
| May 7, 2026 | 3.48 | 3.66 | 3.82 |
| May 6, 2026 | 3.52 | 3.70 | 3.87 |
| May 5, 2026 | 3.47 | 3.64 | 3.81 |
NGEN shares fell -3.17% in Monday, May 4, 2026's trading session, dropping from a previous close of $3.78 to move at $3.66. The stock demonstrated notable intraday movement (see NGEN's key stats for a full breakdown), fluctuating between $3.62 and $3.84, a +6.05% trading range. While recent weeks have seen some volatility, NGEN has managed to secure a -10.07% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 147.66K shares changing hands, 58.06K fewer than the previous session. This amounted to $540.42K in total market activity.
Will NGEN Continue Its Downward Trend?
According to analyst ratings and projections for NGEN, NervGen Pharma Corp. Common stock shares are anticipated to decrease by -1.77%, potentially reaching $3.60 per share by May 18, 2026. Short-term technical indicators currently suggest a neutral sentiment for NGEN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the NGEN stock forecast, now is not the best time to buy NGEN stock because its current trading price is +7.02% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on NGEN covering social and institutional perspectives.
NGEN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into NGEN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 36.90% to 42.78%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 46.80%, suggests a neutral medium-term outlook. Insights into NGEN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
NervGen Pharma Common stock Short-Term Forecasts
NGEN Forecast For Next 5 Days
Our algorithm anticipates NervGen Pharma Common stock (NGEN) stock could hit $3.69 by May 11, 2026. This represents a +0.94% fall from today's price, following a - change over the past five days.
NGEN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for NervGen Pharma Corp. Common stock (NGEN) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.84, which would mean a +4.92% increase from the current price of $3.66. Projections for this period range from a high of $4.16 to a low of $3.44.
NGEN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for NervGen Pharma Common stock's price over the next three months point to a rise. NGEN stock is expected to peak at $19.82 on May 21, 2026 after potentially dipping to $11.53 on May 11, 2026. On average, NGEN is likely to trade around $15.11 in the coming 90 days.
NervGen Pharma Common stock Stock Forecast 2025
Based on our predictive models, NervGen Pharma Common stock (NGEN) is expected to trade between $4.96 and $19.82 throughout 2026. This would result in an average price of $11.17, potentially offering investors a +205.19% return from current levels.
NervGen Pharma Corp. Common stock Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, NervGen Pharma Corp. Common stock (NGEN) is positioned to show a strong performance in May 2026. The price is predicted to move between $11.53 and $19.82, settling at an average of $15.54. This could translate to a +324.59% gain.
June 2026
Based on current market signals, NervGen Pharma Corp. Common stock is projected to trend june 2026. We forecast a trading range from $13.89 to $18.42, with a likely average price of $16.34. Investors could expect a potential return of +346.45%.
July 2026
Our predictive algorithms indicate NervGen Pharma Corp. Common stock stock may see a shift in July 2026. The expected range spans $12.43–$14.78, with an average target of $13.89. This represents a positive outlook and a possible gain of +279.51%.
August 2026
Analyzing established trends, NervGen Pharma Corp. Common stock looks set to move in August 2026. Projections place the stock between $11.19 and $12.77, averaging around $12.12. This suggests a +231.15% gain from current levels.
September 2026
Market indicators suggest NervGen Pharma Corp. Common stock could experience notable changes during September 2026. Prices could fluctuate within $9.88 to $11.46, with a midpoint forecast of $10.64. The stock might deliver a +190.71% gain.
October 2026
Forecasting for October 2026, models estimate that NervGen Pharma Corp. Common stock may undergo key fluctuations. If trends hold, the stock might trade between $6.76 and $10.13, averaging $8.22. This signals a positive trajectory with potential returns around +124.59%.
November 2026
According to our latest forecast models, NervGen Pharma Corp. Common stock (NGEN) is positioned to show a strong performance in November 2026. The price is predicted to move between $6.27 and $8.38, settling at an average of $7.43. This could translate to a +103.01% gain.
December 2026
Based on current market signals, NervGen Pharma Corp. Common stock is projected to trend december 2026. We forecast a trading range from $4.96 to $6.55, with a likely average price of $5.78. Investors could expect a potential return of +57.92%.
January 2027
Our predictive algorithms indicate NervGen Pharma Corp. Common stock stock may see a shift in January 2027. The expected range spans $4.35–$5.37, with an average target of $4.95. This represents a positive outlook and a possible gain of +35.25%.
February 2027
Analyzing established trends, NervGen Pharma Corp. Common stock looks set to move in February 2027. Projections place the stock between $3.57 and $4.28, averaging around $3.77. This suggests a +3.01% gain from current levels.
March 2027
Market indicators suggest NervGen Pharma Corp. Common stock could experience notable changes during March 2027. Prices could fluctuate within $2.21 to $3.53, with a midpoint forecast of $2.82. The stock might deliver a -22.95% loss.
April 2027
Forecasting for April 2027, models estimate that NervGen Pharma Corp. Common stock may undergo key fluctuations. If trends hold, the stock might trade between $1.87 and $2.99, averaging $2.54. This signals a cautious trajectory with potential returns around -30.60%.
May 2027
According to our latest forecast models, NervGen Pharma Corp. Common stock (NGEN) is positioned to show a strong performance in May 2027. The price is predicted to move between $1.79 and $1.93, settling at an average of $1.85. This could translate to a -49.45% loss.
NGEN's history of dividends and stock splits also plays a role in long-term investor confidence.